MENU
CPRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Catalyst Pharmaceuticals (CPRX) Ownership - Who owns Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases... Show more

Profile

Industry
Pharmaceuticals Other
Address
355 Alhambra Circle
Phone
+1 305 420-3200
Employees
182
Web
https://www.catalystpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.83B
P/E Ratio
18.08
Total Cash
755.86M
Projected Growth
N/A
Total Debt
2.68M
Revenue
596.96M
Risk (Beta)
0.92
Dividend Yield
N/A
Total Cash/Share
6.18
Total Debt/Equity
N/A
Revenue/Share
4.69 USD as % of share price
View a ticker or compare two or three
CPRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of prescription drugs

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
355 Alhambra Circle
Phone
+1 305 420-3200
Employees
182
Web
https://www.catalystpharma.com